BrianLVanderBeekMDMPH MSCE

Ophthalmology • Philadelphia, PA

Retinal Disease

Assistant Professor, Ophthalmology, Perelman School of Medicine

Join to view full profile

Dr. VanderBeek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. VanderBeek's full profile

Already have an account?

Office
51 N. 39th Street
Philadelphia, PA 19104
Phone+1 215-662-8676

Education & Training

University of Michigan Health SystemFellowship, Surgical Retina and Vitreous, 2009 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 2006 - 2009
Christ HospitalInternship, Internal Medicine, 2005 - 2006
University of Cincinnati College of MedicineClass of 2005

Certifications & Licensure

PA State Medical License 2011 - 2024
MI State Medical License 2009 - 2013
NY State Medical License 2007 - 2010
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Disparities in glaucoma and macular degeneration healthcare utilization among persons living with dementia in the United States.
Ali G Hamedani, Angela Y Chang, Yineng Chen, Brian L VanderBeek
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2024-12-01
1 citations
Do Treatment Patterns for Endophthalmitis after Cataract Surgery Follow the Endophthalmitis Vitrectomy Study Recommendations?: An Academy IRIS® Registry Analysis.
Maurizio Tomaiuolo, Jordan Deaner, Brian L VanderBeek, Binod Acharya, Zeba A Syed
Ophthalmology. Retina. 2024-11-01
Glucagon-Like Peptide-1 Receptor Agonists are Not Associated with an Increased Risk of Progressing to Vision-Threatening Diabetic Retinopathy.
Zujaja Tauqeer, Peter Bracha, Peiying Hua, Yinxi Yu, Qi N Cui
Ophthalmic Epidemiology. 2024-10-10

Journal Articles

Curtailing Opioid Overprescribing in Ophthalmology
Anton M Kolomeyer, Brian L Vanderbeek, JAMA Ophthalmology

Press Mentions

Sexual-Enhancement Drugs Raise Risk of Vision ImpairmentApril 18th, 2022
Erectile Dysfunction Drugs Linked to Vision LossApril 11th, 2022
ED Meds Linked to Higher Risk of Ocular Adverse EventsApril 7th, 2022
Join now to see all